Format

Send to

Choose Destination
See comment in PubMed Commons below
Cleve Clin J Med. 2012 Nov;79 Suppl 3:S38-45. doi: 10.3949/ccjm.79.s3.09.

Safety issues in vasculitis: infections and immunizations in the immunosuppressed host.

Author information

  • 1Department of Infectious Diseases, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, USA. isadac@ccf.org

Abstract

Infectious diseases are a significant cause of morbidity and mortality in immunosuppressed patients, including those with connective tissue diseases. Both disease and treatment contribute to a predisposition to infection in immunocompromised patients. Significant infection and morbidity occur in 25% to 50% of these patients with a median mortality of 5.2% due to common bacterial infections, such as pneumonia or bacteremia, and opportunistic fungal infections such as Pneumocystis. The lungs, skin, urinary tract, blood, and central nervous system are commonly affected. Pathogens such as Pneumocystis jirovecii, Histoplasma capsulatum, Aspergillus species, herpes zoster, JC virus, Nocardia asteroides, and Nocardia species are increasingly prevalent in immunocompromised patients. Improved recognition, diagnosis, and prevention of these infections are needed to enhance outcomes in these patients.

PMID:
23203645
DOI:
10.3949/ccjm.79.s3.09
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Cleveland Clinic
    Loading ...
    Support Center